Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7552d20057e28e83002141e7a2c63002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e40ceab05afbe887909abf7467edd987 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8206 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8213 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22 |
filingDate |
2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe92a6038b9f9dc762a47a0aff21d051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b10e473c5c1fc4cdb789fdb04b5321e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_029144798d657208bfa375b860aeefbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdd3d01034f42a1e45445cb1de093769 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_980e887d350096787fcef240676640eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a8d222a834f6fe24248427242d804ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4922d88b4696cf1e9f874390c88fc485 |
publicationDate |
2020-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020263782-A1 |
titleOfInvention |
Methods and compositions for modifying nucleic acids and for killing cells |
abstract |
The present invention relates generally to methods of modifying the genome of an organism comprising contacting genome of the organism with a composition comprising a CRISPR-Cas nucleic acid and a polyalkyleneimine-alkoxylene polymer such as a polyethyleneimine (PEI)-polyethylene oxide (PEO) polymer. The present invention also relates to methods of using the compositions of the invention to kill cells. |
priorityDate |
2019-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |